Obese women in Canada are less likely to be screened for cervical cancerJune 18, 2008University of Alberta study Research in the United States has shown that obese people are less likely than their normal-weight peers to undergo screening for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell and Scott Klarenbach, from the University of Alberta's Faculty of Medicine & Dentistry, have undertaken a study to see if this trend is also true in Canada. "As obesity is associated with higher rates of some types of cancer, it's important to determine if the presence of obesity influences the use of screening tests," said Padwal. In 2007 almost 38,000 women participated in a national survey. The women, aged 20-69, were asked questions including: * their Body Mass Index (to determine the level of obesity) * whether they have a regular doctor * did they get breast, colon and cervical cancer screening tests regularly; if so, how often; if not, what are the reasons? Padwal said for the most part, the results were encouraging. For breast and colon cancer screening the data showed no difference between overweight/obese women and normal-weight women. But for cervical cancer screening the results were different. While 82 per cent of women said they had a pap smear in the past three years, testing decreased as BMI levels increased. "Obese women are 30 to 40 per cent less likely-depending on the degree of obesity-to have recommended cervical cancer screening performed." Padwal says the results also showed obese women are two times more likely than normal-weight women to state that fear-including fear of pain, embarrassment or of finding something wrong-was the reason they did not have a pap smear. "I am reassured that for mammograms and colorectal cancer screening, the presence of obesity doesn't impact their use, which is different from reports in other countries. However, the gap with pap smears is concerning," he said. Padwal believes this is an issue that needs to be addressed through increased awareness and vigilance on the part of patients and health care providers. He says more studies are needed to determine if other barriers exist and, if so, what are the best methods of removing those barriers. University of Alberta |
|||||||||||||||||||||
| Related Cervical Cancer Current Events and Cervical Cancer News Articles 1 disease, not 1 demographic The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists. M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers. Study finds delay in follow-up among African-American women receiving abnormal breast finding A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality. UIC study finds girls aware of HPV vaccine's benefits Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections. Scientists identify common HPV genotypes in northern India, encourage vaccination Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region. Vaccinating boys against human papillomavirus not cost-effective Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Vaccination and testing for the human papilloma virus could eradicate cervical cancer Cervical cancer could be eradicated within the next 50 years if countries implement national screening programmes based on detection of the human papilloma virus (HPV), which causes the disease, together with vaccination programmes against the virus, according to a cervical cancer screening expert. Targeted heat therapy offers new standard treatment option for soft tissue sarcoma Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. Even in a safety net health system, colorectal cancer screening disparities remain Colorectal cancer screening rates are much lower among those in a safety net health system compared to the national average, and the number one predictor of screening is a combination of regular visits and insurance access. More Cervical Cancer Current Events and Cervical Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||